Published in Arch Biochem Biophys on April 25, 2007
AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential. J Cell Mol Med (2008) 1.23
Caveolin-1 interacts with Derlin-1 and promotes ubiquitination and degradation of cyclooxygenase-2 via collaboration with p97 complex. J Biol Chem (2013) 0.88
Establishment of an in vitro transport assay that reveals mechanistic differences in cytosolic events controlling cholera toxin and T-cell receptor α retro-translocation. PLoS One (2013) 0.82
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell (2000) 13.44
Recognition of the polyubiquitin proteolytic signal. EMBO J (2000) 10.12
Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol (2003) 9.85
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90
The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature (2001) 7.59
ERAD: the long road to destruction. Nat Cell Biol (2005) 7.46
Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science (2006) 6.75
A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature (2004) 6.37
A membrane protein required for dislocation of misfolded proteins from the ER. Nature (2004) 5.39
Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins. Cell (1988) 4.42
Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol (2003) 4.35
Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol (2002) 4.29
Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol (2002) 4.06
AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol (2002) 3.77
Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell (1995) 3.44
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc Natl Acad Sci U S A (2001) 3.39
Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J Biol Chem (2003) 2.96
The T cell antigen receptor: insights into organelle biology. Annu Rev Cell Biol (1990) 2.91
Endoplasmic reticulum-associated degradation. Annu Rev Cell Dev Biol (2005) 2.83
For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J (2003) 2.82
Cytosolic degradation of T-cell receptor alpha chains by the proteasome. J Biol Chem (1997) 2.66
Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly. J Cell Biol (1989) 2.65
Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell (2006) 2.54
Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell (1998) 2.54
Colocalized transmembrane determinants for ER degradation and subunit assembly explain the intracellular fate of TCR chains. Cell (1990) 2.49
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J Cell Sci (2003) 2.21
The alpha chain of the T cell antigen receptor is degraded in the cytosol. Immunity (1997) 2.20
A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science (1990) 2.17
Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes. Nature (1987) 2.11
Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. EMBO J (1991) 2.08
Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol Biol Cell (2006) 2.07
The role of multiubiquitination in dislocation and degradation of the alpha subunit of the T cell antigen receptor. J Biol Chem (1999) 1.90
Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I. J Biol Chem (2003) 1.86
Cdc48-Ufd1-Npl4: stuck in the middle with Ub. Curr Biol (2002) 1.75
Endoplasmic reticulum (ER)-associated degradation of T cell receptor subunits. Involvement of ER-associated ubiquitin-conjugating enzymes (E2s). J Biol Chem (2001) 1.74
The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol (2005) 1.64
The engagement of Sec61p in the ER dislocation process. Mol Cell (1999) 1.57
The gamma and epsilon subunits of the CD3 complex inhibit pre-Golgi degradation of newly synthesized T cell antigen receptors. J Cell Biol (1990) 1.42
Mass spectrometric mapping and sequencing of N-linked oligosaccharides derived from submicrogram amounts of glycoproteins. Anal Chem (1998) 1.37
Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells. Int Immunol (1991) 1.36
The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast. Curr Top Microbiol Immunol (2005) 1.34
Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? Trends Cell Biol (2004) 1.29
Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains. J Biol Chem (2003) 1.27
A role for mammalian Ubc6 homologues in ER-associated protein degradation. J Cell Sci (2002) 1.26
Associations between subunit ectodomains promote T cell antigen receptor assembly and protect against degradation in the ER. J Cell Biol (1993) 1.08
Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates. Exp Cell Res (2006) 1.04
Recognition of a single transmembrane degron by sequential quality control checkpoints. Mol Biol Cell (2003) 1.00
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics (2006) 2.48
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta (2009) 2.07
Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol Biol Cell (2006) 2.07
Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem (2008) 1.96
Eastern Europe: progress stifled by the old guard. Nature (2004) 1.86
Structural investigations of glycoconjugates at high sensitivity. Chem Rev (2002) 1.79
High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.74
Individual and gender fingerprints in human body odour. J R Soc Interface (2007) 1.65
Characterization of glycopeptides by combining collision-induced dissociation and electron-transfer dissociation mass spectrometry data. Rapid Commun Mass Spectrom (2009) 1.60
Development of high-sensitivity ion trap ion mobility spectrometry time-of-flight techniques: a high-throughput nano-LC-IMS-TOF separation of peptides arising from a Drosophila protein extract. Anal Chem (2003) 1.54
Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res (2009) 1.52
Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. Anal Chem (2010) 1.47
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res (2012) 1.46
Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics (2009) 1.45
Pheromone binding by polymorphic mouse major urinary proteins. Protein Sci (2002) 1.39
Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. PLoS One (2015) 1.38
Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS. J Am Soc Mass Spectrom (2008) 1.37
Structural characterization of oligosaccharides using MALDI-TOF/TOF tandem mass spectrometry. Anal Chem (2003) 1.27
Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med (2008) 1.26
Comparative glycomic mapping through quantitative permethylation and stable-isotope labeling. Anal Chem (2007) 1.26
Electrophoretic analysis of N-glycans on microfluidic devices. Anal Chem (2007) 1.26
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J (2008) 1.24
ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Commun Mass Spectrom (2008) 1.24
High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev (2013) 1.23
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis (2010) 1.22
Solid-phase permethylation for glycomic analysis. Methods Mol Biol (2009) 1.21
Cardiotoxicity of the anticancer therapeutic agent bortezomib. Am J Pathol (2010) 1.17
A proteomic survey of rat cerebral cortical synaptosomes. Proteomics (2005) 1.16
Characterizing protein glycosylation sites through higher-energy C-trap dissociation. Rapid Commun Mass Spectrom (2010) 1.16
Advancement in protein inference from shotgun proteomics using peptide detectability. Pac Symp Biocomput (2007) 1.15
Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res (2009) 1.14
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity. Blood (2010) 1.13
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci U S A (2006) 1.13
Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J Proteome Res (2010) 1.13
The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics (2006) 1.12
Application of dissimilarity indices, principal coordinates analysis, and rank tests to peak tables in metabolomics of the gas chromatography/mass spectrometry of human sweat. Anal Chem (2007) 1.12
Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res (2008) 1.12
Automated interpretation of MS/MS spectra of oligosaccharides. Bioinformatics (2005) 1.12
Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal Chem (2005) 1.11
Improving confidence in detection and characterization of protein N-glycosylation sites and microheterogeneity. Rapid Commun Mass Spectrom (2011) 1.10
Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res (2010) 1.10
Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res (2004) 1.09
Efficacy of glycoprotein enrichment by microscale lectin affinity chromatography. J Sep Sci (2008) 1.08
LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma. J Proteome Res (2014) 1.08
A monolithic PNGase F enzyme microreactor enabling glycan mass mapping of glycoproteins by mass spectrometry. Rapid Commun Mass Spectrom (2005) 1.06
Miniaturized separation techniques in glycomic investigations. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.06
Thermodynamic consequences of disrupting a water-mediated hydrogen bond network in a protein:pheromone complex. Protein Sci (2005) 1.06
Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum. Electrophoresis (2012) 1.06
Songbird chemosignals: volatile compounds in preen gland secretions vary among individuals, sexes, and populations. Behav Ecol (2010) 1.05
Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem (2002) 1.04
Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates. Exp Cell Res (2006) 1.04
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics (2013) 1.03
Multimethodological approach to identification of glycoproteins from the proteome of Francisella tularensis, an intracellular microorganism. J Proteome Res (2010) 1.03
Seasonal variation in volatile compound profiles of preen gland secretions of the dark-eyed junco (Junco hyemalis). J Chem Ecol (2007) 1.02
New hyphenated methodologies in high-sensitivity glycoprotein analysis. J Sep Sci (2005) 1.02
High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.02
Computational framework for identification of intact glycopeptides in complex samples. Anal Chem (2013) 1.01
Thermodynamic analysis of binding between mouse major urinary protein-I and the pheromone 2-sec-butyl-4,5-dihydrothiazole. Biochemistry (2003) 1.01
Decreased ER-associated degradation of alpha-TCR induced by Grp78 depletion with the SubAB cytotoxin. Int J Biochem Cell Biol (2008) 1.00
Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. Electrophoresis (2011) 0.99
Chemotaxis assays of mouse sperm on microfluidic devices. Anal Chem (2006) 0.98
Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue. J Biol Chem (2010) 0.98
Identification of isomeric N-glycan structures by mass spectrometry with 157 nm laser-induced photofragmentation. J Am Soc Mass Spectrom (2008) 0.97